posted by user: mme_123 || 2243 views || tracked by 4 users: [display]

PMTC 2013 : International Conference of Personalized Medicine and Targeted Therapies in Cancer

FacebookTwitterLinkedInGoogle

Link: http://pmtc2013.com/call_for_abstracts.html
 
When Jan 31, 2013 - Feb 2, 2013
Where Sharjah
Abstract Registration Due Dec 1, 2012
Submission Deadline Oct 15, 2012
Notification Due Nov 15, 2012
Categories    tumor progression   cancer biomarkers   chemotherapy resistance
 

Call For Papers

The Scientific Committee welcomes the submission of abstracts for oral or poster presentations at PMTC2013 from professionals, researchers and students in the Personalized Medicine and Targeted Therapies in Cancer field and related subspecialties.

Deadline
Deadline for abstract submission is 15 October 2012, 8pm local UAE time.

Topics
Tumor progression: basic and therapeutic aspects
Cancer biomarkers
Aberrant signaling pathways in malignancy
Novel targeted therapy in cancer
Chemotherapy resistance
Pharmacogenomics, personalized diagnostics and medicine
Genome project on drug development and cancer therapy
Epigenetics and its impact on cancer therapy


Author Agreement
By submitting the abstract, the author confirms and agrees to the following:
a. All authors approve submitting this work for presentation.
b. The authors have done the work reported in the abstract and take full responsibility for the contents.
c. The authors transfer all copyright ownership of the abstract to the PMTC2013.
d. The authors agree to confine their presentation to information in the abstract.
e. At least one author will be available to present the abstract if accepted for presentation.
f. The author will immediately notify the PMTC2013 Scientific Committee if they are unable to make a presentation or if the presenting author has to be changed.
g. The authors guarantee that clinical studies and any animal tests have proceeded with the official permission from the proper authorities.
h. All presenters will be responsible for their own registration fees, hotel and travel expenses. We regret that we cannot waive registration fees or cover expenses for any oral or poster presenters.

Important Dates:
1 May 2012: Abstract submission opens for poster and oral presentations

15 Oct 2012: Deadline for abstract submission

15 Nov 2012: Abstract acceptance notification to first authors

1 Dec 2012: All presenting authors must be registered

Guidelines for Abstract Submission
A special criterion for accepting abstracts will be their topic as well as structure, content and degree of novelty.

Structure of the Abstract
The structure of the abstract should be as follows:
a. Background and Objectives
b. Methods
c. Results
d. Conclusions

Please note that a maximum of 300 words is permitted. The titles and the names of the authors are excluded from this number and have to be entered separately. Tables should not be included in the abstract body.
Methods section should include type of statistical analysis done if applicable to the study.

Related Resources

TCPIAIA 2024   Targeted Chemotherapy with Personalized Immunotherapy: An AI Approach
EAICI 2024   Explainable AI for Cancer Imaging
AIME 2024   22nd International Conference of Artificial Intelligence in Medicine
5th Cell Therapies and Immunotherapy Con 2024   5th Cell Therapies and Immunotherapy Conference
IEEE-EMBS BHI 2024   IEEE-EMBS International Conference on Biomedical and Health Informatics
IMIP 2024   2024 6th International Conference on Intelligent Medicine and Image Processing (IMIP 2024)
ICMHI 2024   ACM--2024 8th International Conference on Medical and Health Informatics (ICMHI 2024)
DMM&L 2024   2nd International Conference on Decision Making in Medicine and Law: Opportunities and pitfalls of information technologies
DMIP 2024   ACM--2024 7th International Conference on Digital Medicine and Image Processing (DMIP 2024)
MDA 2024   19th International Conference on Mass Data Analysis of Images and Signals with Applications in Medicine, r/g/b Biotechnology, Food Industries and Dietetics, Biomet